Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
FAQs
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Tags:
Australia Regulation Medical Device

Cost Pressures Prompt Possible Device Fee Increases In Australia

Regulator proposes potentially slower device reviews or higher fees

  • News

Executive Summary

The Australian regulator is dealing with increased cost pressures and has listed three possible options for fee-related changes affecting the medical devices and medicines sector.

You may also be interested in...



Time Is Ripe For Global Action On Orphan Biosimilars

European industry association wants global convergence on development requirements, though the European Medicines Agency says that this would prove challenging.

Time Is Ripe For Global Action On Orphan Biosimilars

European industry association wants global convergence on development requirements, though the European Medicines Agency says that this would prove challenging.

Australia Pushes For More Drug Repurposing

Proposals on how to encourage more applications for new uses of repurposed drugs could see some significant changes, including an obligation on sponsors to file for new indications. 

Table

View full table

Topics

Tags:
Australia Regulation Medical Device
UsernamePublicRestriction

Register

LL1131980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By